Quanome agrees to acquire 5% stake in QAI Labs in $5 million all-stock deal
QNME•Quanome Technologies agreed to invest $5 million in QAI Labs for an approximately 5% stake, issuing 6,541,236 shares of its common stock in exchange for 31,579 new QAI Labs shares. The deal implies a $100 million equity valuation for QAI Labs, which will remain independent.
1. Investment terms
Quanome Technologies agreed on November 4, 2026, to acquire an approximately 5% stake in QAI Labs in an all-stock investment valued at $5 million. QAI Labs will issue 31,579 new shares in exchange for 6,541,236 shares of Quanome common stock.
2. Share issuance
The issuance represents approximately 19% of Quanome's outstanding shares before issuance and 15.97% afterward. The transaction implies an approximately $100 million equity valuation for QAI Labs, which will remain independent.
3. Closing conditions
The investment targets AI-driven antibody discovery, and closing remains subject to customary conditions.
